209 related articles for article (PubMed ID: 34433585)
1. Fam20C Regulates Bone Resorption and Breast Cancer Bone Metastasis through Osteopontin and BMP4.
Zuo H; Yang D; Wan Y
Cancer Res; 2021 Oct; 81(20):5242-5254. PubMed ID: 34433585
[TBL] [Abstract][Full Text] [Related]
2. Ras-transformation reduce FAM20C expression and osteopontin phosphorylation.
Schytte GN; Christensen B; Bregenov I; Sørensen ES
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830861
[TBL] [Abstract][Full Text] [Related]
3. Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis.
Eckhardt BL; Cao Y; Redfern AD; Chi LH; Burrows AD; Roslan S; Sloan EK; Parker BS; Loi S; Ueno NT; Lau PKH; Latham B; Anderson RL
Cancer Res; 2020 Mar; 80(6):1304-1315. PubMed ID: 31941699
[TBL] [Abstract][Full Text] [Related]
4. Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis.
Tibaldi E; Brocca A; Sticca A; Gola E; Pizzi M; Bordin L; Pagano MA; Mazzorana M; Donà G; Violi P; Marin O; Romano A; Angeli P; Carraro A; Brunati AM
FASEB J; 2020 Jan; 34(1):1122-1135. PubMed ID: 31914633
[TBL] [Abstract][Full Text] [Related]
5. The impact of bone morphogenetic protein 4 (BMP4) on breast cancer metastasis in a mouse xenograft model.
Ampuja M; Alarmo EL; Owens P; Havunen R; Gorska AE; Moses HL; Kallioniemi A
Cancer Lett; 2016 Jun; 375(2):238-244. PubMed ID: 26970275
[TBL] [Abstract][Full Text] [Related]
6. Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis.
Jiang M; Yan Y; Yang K; Liu Z; Qi J; Zhou H; Qian N; Zhou Q; Wang T; Xu X; Xiao X; Deng L
J Cell Mol Med; 2019 Feb; 23(2):1224-1234. PubMed ID: 30461194
[TBL] [Abstract][Full Text] [Related]
7. FAM20C regulates osteoblast behaviors and intracellular signaling pathways in a cell-autonomous manner.
Liu C; Zhang H; Jani P; Wang X; Lu Y; Li N; Xiao J; Qin C
J Cell Physiol; 2018 Apr; 233(4):3476-3486. PubMed ID: 28926103
[TBL] [Abstract][Full Text] [Related]
8. Knocking out FAM20C in pre-osteoblasts leads to up-regulation of osteoclast differentiation to affect long bone development.
Jiang L; Liu X; Liu L; Su L; Lu Z; Zhang H; Guo Y; Zhang W; Zhang S; Xu W; Zhang J; Zhang K; Zhan Y; Xie X; Li R; Dong X; Jin H; Zhang B; Li Y
Gene; 2024 Jul; 915():148396. PubMed ID: 38552750
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin as a multifaceted driver of bone metastasis and drug resistance.
Pang X; Gong K; Zhang X; Wu S; Cui Y; Qian BZ
Pharmacol Res; 2019 Jun; 144():235-244. PubMed ID: 31028902
[TBL] [Abstract][Full Text] [Related]
10. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.
Guo D; Huang J; Gong J
Mol Cell Biochem; 2012 Apr; 363(1-2):179-90. PubMed ID: 22167620
[TBL] [Abstract][Full Text] [Related]
12. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of secretory pathway kinase Fam20C by site-1 protease promotes biomineralization.
Chen X; Zhang J; Liu P; Wei Y; Wang X; Xiao J; Wang CC; Wang L
Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34349020
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signaling.
Sung B; Oyajobi B; Aggarwal BB
Mol Cancer Ther; 2012 Feb; 11(2):350-9. PubMed ID: 22090419
[TBL] [Abstract][Full Text] [Related]
16. A Single Kinase Generates the Majority of the Secreted Phosphoproteome.
Tagliabracci VS; Wiley SE; Guo X; Kinch LN; Durrant E; Wen J; Xiao J; Cui J; Nguyen KB; Engel JL; Coon JJ; Grishin N; Pinna LA; Pagliarini DJ; Dixon JE
Cell; 2015 Jun; 161(7):1619-32. PubMed ID: 26091039
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin: an effector and an effect of tumor metastasis.
Shevde LA; Das S; Clark DW; Samant RS
Curr Mol Med; 2010 Feb; 10(1):71-81. PubMed ID: 20205680
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
20. Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer.
Qin Z; Wang P; Li X; Zhang S; Tian M; Dai Y; Fu L
Mol Biosyst; 2016 Jun; 12(7):2108-18. PubMed ID: 27113542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
